Basilea Pharmaceutica
Manufacturing · Switzerland · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Hegenheimermattweg 167b, Allschwil, Base...Phone Number
+41 616061111Website
www.basilea.comRevenue
$187.5 MillionStock Symbol
BSLNIndustry
About Basilea Pharmaceutica
Is Basilea Pharmaceutica your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Basilea Pharmaceutica had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Basilea Pharmaceutica
Funding: Get notified immidiatlly once Basilea Pharmaceutica has new funding data
Basilea Pharmaceutica, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Basilea Pharmaceutica is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Basilea Pharmaceutica has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Basilea Pharmaceutica recently announced quarterly report
Product Launch: Get notified when Basilea Pharmaceutica launches new products
Recommended Actions
Reach out to Masked Content who joined Basilea Pharmaceutica as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Basilea Pharmaceutica is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Basilea Pharmaceutica is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Basilea Pharmaceutica.
Basilea Pharmaceutica Tech Stack
A closer look at the technologies used by Basilea Pharmaceutica
Most Recent Scoops
Basilea Pharmaceutica News & Media
Basilea reports strong 2026 half-year results and raises full-year guidance; fosmanogepix phase 3 program on track
Ad hoc announcement pursuant to Art. 53 LRBasilea receives additional USD 5.4 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
Ad hoc announcement pursuant to Art. 53 LRBasilea receives USD 30 million funding under existing BARDA agreement for advancing phase 3 development of novel antifungal fosmanogepix
Ad hoc announcement pursuant to Art. 53 LRBasilea receives further USD 13 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
US BARDA awarded Basilea USD 13.3 million to continue the development of Basilea’s novel oral antibiotic ceftibuten-ledaborbactam.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Basilea Pharmaceutica
Founded in 2000, Basilea Pharmaceutica is a commercial-stage biopharmaceutical company that specializes in the development of products for the therapeutic areas of oncology and infectious diseases. Basilea Pharmaceutica is located in Switzerland.... Read More